Albany Molecular Research Inc
AMRI
AMRI was delisted on the 31st of August, 2017.
133 hedge funds and large institutions have $581M invested in Albany Molecular Research Inc in 2016 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 50 increasing their positions, 40 reducing their positions, and 17 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 40
15% more capital invested
Capital invested by funds: $506M → $581M (+$74.8M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less funds holding
Funds holding: 137 → 133 (-4)
12% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 17
99% less call options, than puts
Call options by funds: $1.33M | Put options by funds: $90.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WC
Walthausen & Co
Malta,
New York
|
+$10.3M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$6.11M |
| 3 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$4.76M |
| 4 |
PIP
Permian Investment Partners
Dallas,
Texas
|
+$4.73M |
| 5 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
+$2.42M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$5.6M |
| 2 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$5.11M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$4.9M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.88M |
| 5 |
EWM
Evercore Wealth Management
New York
|
-$1.83M |
AMRI Hedge Fund Activity: Q4 2016 in Review
133 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q4 2016, worth a combined $581M — up 15% from $506M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of AMRI and 15 opened new positions — a net loss of 2 holders — while 40 trimmed existing stakes and 50 added.
The largest buyer was Walthausen & Co, adding an estimated $10.3M. The largest seller was Clough Capital Partners, cutting an estimated $5.6M.
- 133 institutional investors held Albany Molecular Research Inc (AMRI) as of Q4 2016, down from 137 in Q3 2016.
- Funds reported $581M of Albany Molecular Research Inc stock for Q4 2016, up 15% quarter-over-quarter.
- 15 funds opened new Albany Molecular Research Inc positions in Q4 2016 and 17 closed out, a net change of -2 holders.
- The largest Albany Molecular Research Inc buyer in Q4 2016 was Walthausen & Co, an estimated $10.3M added.
- The largest Albany Molecular Research Inc seller in Q4 2016 was Clough Capital Partners, an estimated $5.6M sold.
Based on aggregated 13F filings for Q4 2016.